RET and medullary thyroid gland carcinoma: The study also analyzed patients with RET-mutated and RET fusion-positive MTC patients, where ORR for previously treated, treatment-naïve and fusion-positive previously treated thyroid cancer patients were 60%, 71%, and 89%, respectively [84,85].